Literature DB >> 10639449

Alkyl hydroperoxide reductases C and D are major antigens constitutively expressed by Mycobacterium avium subsp. paratuberculosis.

I Olsen1, L J Reitan, G Holstad, H G Wiker.   

Abstract

Antigens characteristic for Mycobacterium avium subspecies paratuberculosis were identified by crossed immunoelectrophoresis (CIE) and by absorbing out cross-reactive antigens by using a polyclonal and polyvalent Mycobacterium avium subspecies avium antiserum. Two antigens were present in M. avium subsp. paratuberculosis and not detected in Mycobacterium avium subsp. avium. They were identified as antigens 17 and 20 in a CIE reference system for M. avium subsp. paratuberculosis antigens. Purified antigen 20 was identified as alkyl hydroperoxide reductase C (AhpC) while the N-terminal part of purified antigen 17 showed 80% homology with alkyl hydroperoxide reductase D (AhpD) of Mycobacterium tuberculosis. AhpC had a nonreduced mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis corresponding to a molecular mass of 45 kDa and is probably a homodimer linked with disulfide bridges in its native form. AhpD had a mobility corresponding to 19 kDa. Monospecific rabbit antiserum against AhpC and AhpD reacted with 9 strains of M. avium subsp. paratuberculosis but not with 20 other mycobacterial strains except for a Mycobacterium gordonae strain, against which a weak cross-reactive band was produced. Goats experimentally infected with M. avium subsp. paratuberculosis had strong gamma interferon (IFN-gamma) responses toward both AhpC and AhpD, and they also had antibodies against AhpC. The ability of AhpC and AhpD to induce IFN-gamma production shows that these proteins potentially could be used in future vaccines or in diagnostic assays. These results further show that AhpC and AhpD are immunologically important proteins which are constitutively and highly expressed in M. avium subsp. paratuberculosis without the bacteria being submitted to oxidative stress and that the specificities of antigens can be a matter of different levels of protein expression in various species as well as distinct structural differences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639449      PMCID: PMC97208          DOI: 10.1128/IAI.68.2.801-808.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Heterogenous expression of the related MPB70 and MPB83 proteins distinguish various substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv.

Authors:  H G Wiker; S Nagai; R G Hewinson; W P Russell; M Harboe
Journal:  Scand J Immunol       Date:  1996-04       Impact factor: 3.487

2.  Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.

Authors:  D R Sherman; K Mdluli; M J Hickey; T M Arain; S L Morris; C E Barry; C K Stover
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

Review 3.  Loss of oxyR in Mycobacterium tuberculosis.

Authors:  V Deretic; J Song; E Pagán-Ramos
Journal:  Trends Microbiol       Date:  1997-09       Impact factor: 17.079

4.  Characterization of a specific Mycobacterium paratuberculosis recombinant clone expressing 35,000-molecular-weight antigen and reactivity with sera from animals with clinical and subclinical Johne's disease.

Authors:  F A El-Zaatari; S A Naser; D Y Graham
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

Review 5.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

6.  Analysis of culture filtrate and cell wall-associated antigens of Mycobacterium paratuberculosis with monoclonal antibodies.

Authors:  L M Mutharia; W Moreno; M Raymond
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

7.  Production of gamma-interferon by peripheral blood mononuclear cells: an important diagnostic tool for detection of subclinical paratuberculosis.

Authors:  J R Stabel
Journal:  J Vet Diagn Invest       Date:  1996-07       Impact factor: 1.279

8.  Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid.

Authors:  V Deretic; W Philipp; S Dhandayuthapani; M H Mudd; R Curcic; T Garbe; B Heym; L E Via; S T Cole
Journal:  Mol Microbiol       Date:  1995-09       Impact factor: 3.501

9.  Inducible repair of oxidative DNA damage in Escherichia coli.

Authors:  B Demple; J Halbrook
Journal:  Nature       Date:  1983 Aug 4-10       Impact factor: 49.962

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  20 in total

1.  Expression cloning of gamma interferon-inducing antigens of Mycobacterium avium subsp. paratuberculosis.

Authors:  Reiko Nagata; Yoshihiro Muneta; Kazuhiro Yoshihara; Yuichi Yokomizo; Yasuyuki Mori
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 2.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

3.  Surface proteome of "Mycobacterium avium subsp. hominissuis" during the early stages of macrophage infection.

Authors:  Michael McNamara; Shin-Cheng Tzeng; Claudia Maier; Li Zhang; Luiz E Bermudez
Journal:  Infect Immun       Date:  2012-03-05       Impact factor: 3.441

4.  Proteome and differential expression analysis of membrane and cytosolic proteins from Mycobacterium avium subsp. paratuberculosis strains K-10 and 187.

Authors:  Thomas J Radosevich; Timothy A Reinhardt; John D Lippolis; John P Bannantine; Judith R Stabel
Journal:  J Bacteriol       Date:  2006-12-01       Impact factor: 3.490

5.  AhpC, AhpD, and a secreted 14-kilodalton antigen from Mycobacterium avium subsp. paratuberculosis distinguish between paratuberculosis and bovine tuberculosis in an enzyme-linked immunosorbent assay.

Authors:  I Olsen; M Tryland; H G Wiker; L J Reitan
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

6.  Human immune responses to Burkholderia pseudomallei characterized by protein microarray analysis.

Authors:  Duangchan Suwannasaen; Jirawan Mahawantung; Wipada Chaowagul; Direk Limmathurotsakul; Philip L Felgner; Huw Davies; Gregory J Bancroft; Richard W Titball; Ganjana Lertmemongkolchai
Journal:  J Infect Dis       Date:  2011-02-07       Impact factor: 5.226

7.  Expression and immunogenicity of proteins encoded by sequences specific to Mycobacterium avium subsp. paratuberculosis.

Authors:  John P Bannantine; Janis K Hansen; Michael L Paustian; Alongkorn Amonsin; Ling-Ling Li; Judith R Stabel; Vivek Kapur
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

8.  Characterization of novel coding sequences specific to Mycobacterium avium subsp. paratuberculosis: implications for diagnosis of Johne's Disease.

Authors:  Michael L Paustian; Alongkorn Amonsin; Vivek Kapur; John P Bannantine
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

Review 9.  Mycobacterium avium in the postgenomic era.

Authors:  Christine Y Turenne; Richard Wallace; Marcel A Behr
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

10.  A rhodanine agent active against non-replicating intracellular Mycobacterium avium subspecies paratuberculosis.

Authors:  Tim J Bull; Richard Linedale; Jason Hinds; John Hermon-Taylor
Journal:  Gut Pathog       Date:  2009-12-23       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.